Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Choosing which ira index fund offers best value can be tricky. We break down cost, tracking error, and long-term value for you.
26,555 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Investors eye Omada Health as it reports Q1 2026 results. This analysis breaks down the earnings narrative, key metri...
A hidden property tax rule in Charleston can swing long-term retirement funds. The 4% vs 6% assessment gap may add up...
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
JB Straubel’s initial pitch to Elon Musk missed the mark on aviation, but his pivot to electric cars launched Tesla t...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
The market buzz around Sweetgreen stock is loud, but hype isn’t a plan. This article weighs momentum against business...
SoundHound AI stock has slipped in 2026, leaving investors to weigh risk against opportunity. This guide breaks down ...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...
Wall Street is split on two big AI chips players: Intel and Marvell. One stock is riding optimism about data-center d...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...